Evidence map›Paper›PMID 36202365›Full record

ArticleThe Science of the total environment2023

Predicting COVID-19 cases using SARS-CoV-2 RNA in air, surface swab and wastewater samples.

Helena M Solo-Gabriele, Shelja Kumar, Samantha Abelson, Johnathon Penso, Julio Contreras, Kristina M Babler, Mark E Sharkey, Alejandro M A Mantero, Walter E Lamar, John J Tallon and 12 more

Abstract read
In one paragraph

Article in The Science of the total environment, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Predicting COVID-19 Cases Across a Large University Campus Using Built Environment Surveillance.Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors.

Helena M Solo-GabrieleDepartment of Chemical, Environmental, and Materials Engineering, College of Engineering, University of Miami, Coral Gables, FL, United States of America.
Shelja KumarDepartment of Public Health Sciences, Miller School of Medicine, University of Miami, Miami, FL 33136, United States of America.
Samantha AbelsonDepartment of Public Health Sciences, Miller School of Medicine, University of Miami, Miami, FL 33136, United States of America.
Johnathon PensoDepartment of Public Health Sciences, Miller School of Medicine, University of Miami, Miami, FL 33136, United States of America.
Julio ContrerasDepartment of Public Health Sciences, Miller School of Medicine, University of Miami, Miami, FL 33136, United States of America.
Kristina M BablerDepartment of Chemical, Environmental, and Materials Engineering, College of Engineering, University of Miami, Coral Gables, FL, United States of America.
Mark E SharkeyDepartment of Medicine, Miller School of Medicine, University of Miami, Miami, FL, United States of America.
Alejandro M A ManteroDepartment of Public Health Sciences, Miller School of Medicine, University of Miami, Miami, FL 33136, United States of America.
Walter E LamarFacilities Safety & Compliance, Miller School of Medicine, University of Miami, Miami, FL, United States of America.
John J TallonFacilities and Operations, University of Miami, Coral Gables, FL, United States of America.
Erin KobetzDepartment of Medicine, Miller School of Medicine, University of Miami, Miami, FL, United States of America; Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL, United States of America.
Natasha Schaefer SolleDepartment of Medicine, Miller School of Medicine, University of Miami, Miami, FL, United States of America; Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL, United States of America.
Bhavarth S ShuklaDepartment of Medicine, Miller School of Medicine, University of Miami, Miami, FL, United States of America.
Richard J KenneyDepartment of Housing & Residential Life, University of Miami, Coral Gables, FL, United States of America.
Christopher E MasonDepartment of Physiology and Biophysics, Weill Cornell Medical College, New York City, NY, United States of America.
Stephan C SchürerSylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL, United States of America; Institute for Data Science & Computing, University of Miami, Coral Gables, FL, United States of America; Department of Molecular & Cellular Pharmacology, Miller School of Medicine, University of Miami, Miami, FL, United States of America.
Dusica VidovicDepartment of Molecular & Cellular Pharmacology, Miller School of Medicine, University of Miami, Miami, FL, United States of America.
Sion L WilliamsSylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL, United States of America.
George S GrillsSylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL, United States of America.
Dushyantha T JayaweeraDepartment of Medicine, Miller School of Medicine, University of Miami, Miami, FL, United States of America.
Mehdi MirsaeidiDivision of Pulmonary, Critical Care and Sleep, College of Medicine-Jacksonville, University of Florida, Jacksonville, FL, United States of America.
Naresh KumarDepartment of Public Health Sciences, Miller School of Medicine, University of Miami, Miami, FL 33136, United States of America. Electronic address: nkumar@miami.edu.

Funding

University of Miami Developmental Center for AIDS Research (D-CFAR)P30AI073961 · NIAID · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI GWENDOLYN Barbara SCOTT · 2007 to 2026
$33.8M
Miami Clinical and Translational Science InstituteUL1TR002736 · NCATS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI CARRASQUILLO, OLVEEN, KOBETZ, ERIN N · 2018 to 2022
$23.2M
Supplement for MINI point-of-use deviceU01DA053941 · NIDA · UNIVERSITY OF MIAMI CORAL GABLES · PI MASON, CHRISTOPHER EDWARD, SCHURER, STEPHAN C · 2021 to 2022
$5.2M
Dry Eye and MicroenvironmentR01EY026174 · NEI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI GALOR, ANAT, KUMAR, NARESH · 2016 to 2020
$1.9M
NCATS NIH HHS UL1 TR002736NEI NIH HHS R01 EY026174NIAID NIH HHS P30 AI073961NIDA NIH HHS U01 DA053941
6 · The paper itself

Abstract

Genomic footprints of pathogens shed by infected individuals can be traced in environmental samples, which can serve as a noninvasive method of infectious disease surveillance. The research evaluates the efficacy of environmental monitoring of SARS-CoV-2 RNA in air, surface swabs and wastewater to predict COVID-19 cases. Using a prospective experimental design, air, surface swabs, and wastewater samples were collected from a college dormitory housing roughly 500 students from March to May 2021 at the University of Miami, Coral Gables, FL. Students were randomly screened for COVID-19 during the study period. SARS-CoV-2 concentration in environmental samples was quantified using Volcano 2nd Generation-qPCR. Descriptive analyses were conducted to examine the associations between time-lagged SARS-CoV-2 in environmental samples and COVID-19 cases. SARS-CoV-2 was detected in air, surface swab and wastewater samples on 52 (63.4 %), 40 (50.0 %) and 57 (68.6 %) days, respectively. On 19 (24 %) of 78 days SARS-CoV-2 was detected in all three sample types. COVID-19 cases were reported on 11 days during the study period and SARS-CoV-2 was also detected two days before the case diagnosis on all 11 (100 %), 9 (81.8 %) and 8 (72.7 %) days in air, surface swab and wastewater samples, respectively. SARS-CoV-2 detection in environmental samples was an indicator of the presence of local COVID-19 cases and a 3-day lead indicator for a potential outbreak at the dormitory building scale. Proactive environmental surveillance of SARS-CoV-2 or other pathogens in multiple environmental media has potential to guide targeted measures to contain and/or mitigate infectious disease outbreaks within communities.

Indexed as

COVID-19HumansProspective StudiesRNA, ViralSARS-CoV-2WastewaterRNA, ViralWastewaterAir, surface and wastewaterCOVID-19COVID-19 epidemiologyEnvironmental surveillanceSARS-CoV-2

Identifiers

PMID36202365
PMCPMC9529341

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.